Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
The Lancet. Infectious diseases（2023）
摘要
Wellcome Trust, Médecins Sans Frontières Foundation, and the UK Department for International Development.
更多查看译文
关键词
yellow fever vaccine,kenya,doses,hiv-infected,double-blind,non-inferiority
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要